In this video, Dr. Sandra Kurtin, an expert on acute myeloid leukemia (AML), explains that the outlook or prognosis for someone with AML depends on the type they have. Some types of AML have a favorable outlook or prognosis, while other types, including treatment-related or secondary AML, have a poor outlook without a stem cell transplant. Younger people with AML usually have a better outlook than older people. Learning about your AML subtype and any genetic changes you have is very important for understanding your AML prognosis.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.